Navigation Links
Symposium focuses on curable cancer that affects young men
Date:5/14/2008

The latest information on the biology and treatment of testicular cancer, the most common cancer among young men, will be presented at the Symposium on Testicular Cancer organized by the European Society for Medical Oncology (ESMO), to be held on 15-16 May in Munich, Germany.

"Testicular cancer is the most common tumor in men between the ages of eighteen and thirty-five and has seen the strongest increase in incidence among all cancer types over the last 20 years," said the Symposium's Scientific Chair Prof. Hans-Joachim Schmoll, Director of the Department of Internal Medicine for oncology and hematology at the Martin Luther University Halle and former president of the German association for medical oncology (AIO).

Currently, testicular cancer affects one in every 100 men per year in Europe. The causes of the dramatic rise in incidence remain unclear.

The cure rate for testicular cancer has increased dramatically in recent years, thanks to improvements in chemotherapy. As a result, the treatment strategies in virtually all stages of the disease have changed, away from aggressive surgical or radiation treatment to surveillance without treatment or minimal treatment for most patients in early stages and only limited chemotherapy in advanced stages.

"All these changes in treatment approach mean patients need highly informed and experienced doctors, both to give them the best advice on selecting optimal treatment and then to implement with expertise the adopted course," Prof. Schmoll continued.

The ESMO Symposium on Testicular Cancer will present cutting-edge information on the molecular background of testicular cancer. Sessions will focus on explaining the sensitivity of this tumor to chemotherapy, on prognostic factors and on practical decision-making options for individual patients. In particular, treatment options will be discussed against the background of the European Consensus Guidelines.

After the public meeting, the Symposium Faculty will convene for the ESMO International Consensus meeting on Testicular Tumors, to both elaborate several important topics in the field and to update the ESMO Clinical Recommendations (CR) on Testicular seminoma.

Highlights of the meeting include sessions on the biology of germ cell tumors, with presentations by J. Wolter Oosterhuis from the Netherlands and Ewa Rajpert-De Meyts from Denmark. Darren Feldman from the US will also present brand new data on why germ cell tumors are so platinum sensitive and some resistant.


'/>"/>

Contact: Vanessa Pavinato
media@esmo.org
0041-919-731-907
European Society for Medical Oncology
Source:Eurekalert

Related medicine news :

1. 2nd ESMO symposium on soft tissue carcinomas and GIST
2. Smart Balance to Webcast Presentation at Goldman Sachs Consumer Products Symposium
3. Aflac CEO Funds Breast Cancer Symposium in Honor of Companys African-American Female Employees
4. Symposium Targets Critical Manufacturing Topics for Emerging Growth Companies
5. Cardica, Intuitive Surgical, MAQUET Cardiovascular and Transonic to Host Innovations in Revascularization Symposium
6. ATS Medical Announces First Frontiers in Cryoablation Symposium
7. Stem Cells(R) and International Stem Cell Symposium Present Annual Stem Cells(R) Young Investigator Award
8. Symposium at Angioplasty Summit TCT Asia Pacific 2008 Features OrbusNeichs Genous(TM) Bio-engineered R stent(TM)
9. 5W Public Relations Presents the 2008 Body Beautiful Media Symposium Benefiting The Skin Cancer Foundation
10. Symposium to explore role nanoparticles may play in disease
11. NARSADs 5th Annual Mission Possible Symposium Offers Insight to PTSD and Other Mental Illnesses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... 2017 , ... After raising nearly $30,000 on Kickstarter , about three-times ... at a discounted crowdfunding price on Indiegogo . , “Along with creating an ... to bring a fidget toy to the market that was made of superior quality ...
(Date:5/26/2017)... ... May 26, 2017 , ... “When the Stars Lead Home”: a poignant ... of published author Laura Weigel Douglas, an avid reader who lives in the Pacific ... sometimes feels like Green Hills Adventure Camp. She couldn’t be more grateful. , Twelve-year ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... Water damage ... Lee, New Jersey School District had left education officials with a number of critical ... replacement of the flooring had to be accomplished with little or no disruption to ...
(Date:5/24/2017)... ... 24, 2017 , ... NucleusHealth ™, advancing clinical practice ... Food and Drug Administration (FDA) 510(k) clearance for its Nucleus.io ... for medical image management. At the core is patented streaming technology that provides ...
(Date:5/24/2017)... ... May 24, 2017 , ... Myers Jackson is well ... the ability to sell luxury homes anywhere on the planet. The luxury home market ... from Hattiesburg to Houston city-scapes. A quick search of “11 Spyglass Hill Auction will ...
Breaking Medicine News(10 mins):
(Date:5/9/2017)... 9, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... today announced it has earned a spot on ... The Company was ranked among 500 U.S. employers as ... Healthcare Equipment and Services. The annual ... anonymous, independent survey of over 30,000 employees across 25 ...
(Date:5/9/2017)... 2017  Semler Scientific, Inc. (OTCQB: SMLR), an ... improve the clinical effectiveness and efficiency of healthcare ... quarter ended March 31, 2017. ... to identify when preventive care options are appropriate, ... heart attacks or strokes occur," said Doug ...
(Date:5/6/2017)... , May 5, 2017   Provista , a proven ... than 200,000 customers, today announced Jim Cunniff as ... of executive and business experience to Provista, including most recently ... in California . He assumed his new ... is a great fit for Provista," says Jody Hatcher ...
Breaking Medicine Technology: